TrialInternational journal of dermatology2026

Efficacy and Safety of Anti-IL-4Rα Stapokibart in Elderly Patients With Moderate-To-Severe Atopic Dermatitis.

Yan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.